Evaluation of tumour-infiltrating lymphocytes (TILS) and PD-L1 expression in breast cancer of young women

被引：0
|
作者：
Evangelou, Z. [1 ]
Papoudou-Bai, A. [1 ]
Kamina, S. [1 ]
Kourea, E. [1 ]
Stefanou, D. [1 ]
Batistatou, A. [1 ]
机构：
[1] Ioannina Univ Hosp, Pathol, Ioannina, Greece
来源：
VIRCHOWS ARCHIV | 2017年 / 471卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-011
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 50 条
  • [31] Assessment of PD-L1 expression and tumor-infiltrating lymphocytes (TILs) across molecular subtypes of triple-negative breast cancer
    Sood, Ridhi
    Kumar, Sandeep
    Laroiya, Ishita
    Khare, Siddhant
    Das, Ashim
    Singh, Gurpreet
    Bal, Amanjit
    BREAST JOURNAL, 2020, 26 (12): : 2424 - 2427
  • [32] Tumor-infiltrating lymphocytes (TILs) and expression of PD-L1 in melanoma brain metastases (BM).
    Berghoff, Anna Sophie
    Kiesel, Barbara
    Widhalm, Georg
    Rajky, Orsolya
    Ricken, Gerda
    Dieckmann, Karin
    Birner, Peter
    Bartsch, Rupert
    Zielinski, Christoph
    Hoeller, Christoph
    Hainfellner, Johannes A.
    Preusser, Matthias
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer
    Sasagu Kurozumi
    Takaaki Fujii
    Hiroshi Matsumoto
    Kenichi Inoue
    Masafumi Kurosumi
    Jun Horiguchi
    Hiroyuki Kuwano
    Medical Molecular Morphology, 2017, 50 : 185 - 194
  • [34] Expression of programmed death ligand-1 (PD-L1) and tumor infiltrating lymphocytes (TILs) in breast carcinoma and their clinical significance
    Mondal, Santosh Kumar
    Bhattacharya, Saptarshi
    Sarkar, Aditya Prasad
    Saha, Rama
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (SUPPL 1) : S81 - S86
  • [35] Cancer-associated fibroblast senescence and its relation with tumour-infiltrating lymphocytes and PD-L1 expressions in intrahepatic cholangiocarcinoma
    Chuan Lan
    Yuki Kitano
    Yo-ichi Yamashita
    Takanobu Yamao
    Kiyoshi Kajiyama
    Tomoharu Yoshizumi
    Kengo Fukuzawa
    Keishi Sugimachi
    Yasuharu Ikeda
    Hiroshi Takamori
    Nobutomo Miyanari
    Masahiko Hirota
    Hideo Baba
    British Journal of Cancer, 2022, 126 : 219 - 227
  • [36] Tumour infiltrating lymphocytes (TILs) in breast cancer during pregnancy
    Azim, Hatem A., Jr.
    Vingiani, Andrea
    Peccatori, Fedro
    Viale, Giuseppe
    Loi, Sherene
    Pruneri, Giancarlo
    BREAST, 2015, 24 (03): : 290 - 293
  • [37] PD-L1 expression in tumor infiltrating lymphocytes (TILs) inversely correlates with androgen receptor (AR) expression in HER2-positive breast cancer
    Shen, Tiansheng
    Pincus, Jennifer L.
    Siziopikou, Kalliopi P.
    CANCER RESEARCH, 2020, 80 (04)
  • [38] Pattern of tumor-infiltrating lymphocytes (TILs) and PD-L1 expression in primary and metastatic epithelial ovarian cancer (EOC).
    Mesnage, Soizick Jeanne Lynette
    Auguste, Aurelie
    Genestie, Catherine
    Dunant, Ariane
    Pain, Erwann
    Drusch, Francoise
    Gouy, Sebastien
    Morice, Philippe
    Bentivegna, Enrica
    Lhomme, Catherine
    Pautier, Patricia
    Michels, Judith
    Le Formal, Audrey
    Cheaib, Bianca
    Adam, Julien
    Leary, Alexandra
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [39] Tumor Infiltrating Lymphocytes (TILS) and PD-L1 Expression in Breast Cancer: A Review of Current Evidence and Prognostic Implications from Pathologist's Perspective
    Angelico, Giuseppe
    Broggi, Giuseppe
    Tinnirello, Giordana
    Puzzo, Lidia
    Vecchio, Giada Maria
    Salvatorelli, Lucia
    Memeo, Lorenzo
    Santoro, Angela
    Farina, Jessica
    Mule, Antonino
    Magro, Gaetano
    Caltabiano, Rosario
    CANCERS, 2023, 15 (18)
  • [40] Prognostic implication of PD-L1 expression and associated tumor infiltrating lymphocytes in metastatic breast cancer
    Darwish, Mohamed M.
    Riad, Atef Y.
    Salem, Dina A.
    Essa, Ahmad E.
    Shakweer, Marwa M.
    Sherif, Diaa Eldin M.
    IMMUNOPATHOLOGIA PERSA, 2022, 8 (01):
12345